These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 13714760)

  • 1. Serological responses to Asian influenza viruses in man: a comparison of haemagglutination-inhibition and complement-fixation methods.
    HOBSON D; PEARSON E
    Br J Exp Pathol; 1961 Feb; 42(1):53-62. PubMed ID: 13714760
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influenza virus and other viruses. Antiinfluenza vaccine adjuvants. The hemagglutination phenomenon. Non-specific inhibition. II].
    LACORTE JG
    Rev Bras Med; 1960 Apr; 17():334-8. PubMed ID: 13758108
    [No Abstract]   [Full Text] [Related]  

  • 3. The method how to eliminate inhibitors in human serum for the hemagglutination inhibition titration when an Asian P virus was used as an antigen. (Studies on several inhibitors against influenza viruses, 5th report).
    SASAKI H; KABATA Y
    Tohoku J Exp Med; 1961 Feb; 73():247-8. PubMed ID: 13746640
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on serological homgeneity of Asian influenza strains.
    PRINCE AM; TAGUCHI F
    Proc Soc Exp Biol Med; 1963 Jul; 113():766-70. PubMed ID: 13986216
    [No Abstract]   [Full Text] [Related]  

  • 5. INFLUENZA HAEMAGGLUTINATION-INHIBITION ANTIBODIES IN SYDNEY.
    COSSART YE
    J Hyg (Lond); 1964 Jun; 62(2):127-32. PubMed ID: 14171264
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and stabilization of influenza virus antigens for use in hemagglutination-inhibition or complement fixation antibody titrations.
    LYTLE RI; WOLLRIDGE RL
    J Lab Clin Med; 1953 Feb; 41(2):290-5. PubMed ID: 13035262
    [No Abstract]   [Full Text] [Related]  

  • 7. An influenza epidemic in Egypt, 1952-3, with special reference to haemagglutination inhibition.
    ZAGHLOUL IS; RIZK F; KADER MA
    Bull World Health Organ; 1955; 13(2):289-97. PubMed ID: 13260888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The haemagglutination inhibiting antibodies in ferrets crossinfected with influenza A2-virus and strains of the other A-types.
    HARBOE A
    Acta Pathol Microbiol Scand; 1960; 49():22-36. PubMed ID: 14399691
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of complement fixation and haemagglutination inhibition tests in the diagnosis of influenza A.
    Pyhälä R; Kleemola M
    Acta Virol; 1976 Feb; 20(1):66-9. PubMed ID: 7943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FIELD TRIALS OF LIVE ATTENUATED ASIAN INFLUENZA VIRUS VACCINE (OKUNO VACCINE)].
    GOTOE H
    Sapporo Igaku Zasshi; 1963 Sep; 24():211-5. PubMed ID: 14192251
    [No Abstract]   [Full Text] [Related]  

  • 11. [VIROLOGICAL AND SEROLOGICAL RESEARCH MADE DURING THE EPIDEMIC OF INFLUENZA IN FEBRUARY AND MARCH, 1962].
    NAFTA I; ZILIZTEANU E; NICOLESCO IT; GROBNICO M; CRETESCO L; POPESCO A; SATMARI C
    Sem Med; 1963 May; 122():1217-24. PubMed ID: 14065612
    [No Abstract]   [Full Text] [Related]  

  • 12. The normal serum cofactor in the haemagglutination inhibition of influenza A2-virus of low antibody sensitivity by early convalescent ferret serum.
    HARBOE A; STRANDLI O
    Acta Pathol Microbiol Scand; 1962; 56():311-8. PubMed ID: 13952720
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of para-influenza 1 (HA-2) virus. II. Hemagglutination, hemagglutination-inhibition and neutralization.
    DICK EC; MOGABGAB WJ
    Am J Hyg; 1961 May; 73():273-81. PubMed ID: 13722668
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological survey in animals for type A influenza in relation to the 1957 pandemic.
    KAPLAN MM; PAYNE AM
    Bull World Health Organ; 1959; 20(2-3):465-88. PubMed ID: 13651927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peculiarities of haemagglutination inhibition test with type A2 influenza viruses.
    ALEXANDROVA GI
    Acta Virol; 1960 Jan; 4():1-6. PubMed ID: 13848768
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological diagnosis of human influenza infections by immunoprecipitin techniques.
    Schild GC; Winter WD; Brand CM
    Bull World Health Organ; 1971; 45(4):465-71. PubMed ID: 5004707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the experimental results obtained in the course of inactivation of non-specific inhibitors in serum by means of the haemagglutination inhibition and virus neutralization tests.
    HORVATH S
    Arch Gesamte Virusforsch; 1961; 11():295-303. PubMed ID: 13716030
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological characteristics of a "new" serotype of influenza A virus: the Hong Kong strain.
    Masurel N
    Bull World Health Organ; 1969; 41(3):461-8. PubMed ID: 5309456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANTIGENIC VARIANTS OF INFLUENZA A2 VIRUS.
    PEREIRA HG; PEREIRA MS; LAW VG
    Bull World Health Organ; 1964; 31(1):129-32. PubMed ID: 14230885
    [No Abstract]   [Full Text] [Related]  

  • 20. The course of antibody development to influenza A2 strains; examined in the haemagglutination inhibition test with viruses of different sensitivity to homologous antibody.
    HARBOE A; REENAAS R
    Acta Pathol Microbiol Scand; 1959; 46():266-72. PubMed ID: 14399688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.